Anaptysbio (ANAB) Invested Capital (2016 - 2025)
Historic Invested Capital for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to -$29.4 million.
- Anaptysbio's Invested Capital fell 13486.67% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.4 million, marking a year-over-year decrease of 13486.67%. This contributed to the annual value of $70.9 million for FY2024, which is 1956.23% down from last year.
- Per Anaptysbio's latest filing, its Invested Capital stood at -$29.4 million for Q3 2025, which was down 13486.67% from -$44.7 million recorded in Q2 2025.
- Over the past 5 years, Anaptysbio's Invested Capital peaked at $385.7 million during Q2 2021, and registered a low of -$44.7 million during Q2 2025.
- Its 5-year average for Invested Capital is $179.1 million, with a median of $148.4 million in 2023.
- Its Invested Capital has fluctuated over the past 5 years, first surged by 648.59% in 2021, then plummeted by 55280.9% in 2025.
- Quarter analysis of 5 years shows Anaptysbio's Invested Capital stood at $356.4 million in 2021, then dropped by 26.46% to $262.1 million in 2022, then plummeted by 66.39% to $88.1 million in 2023, then fell by 19.56% to $70.9 million in 2024, then plummeted by 141.51% to -$29.4 million in 2025.
- Its Invested Capital stands at -$29.4 million for Q3 2025, versus -$44.7 million for Q2 2025 and $34.0 million for Q1 2025.